PURPOSE: To document variation of transfusion practice following repair of hip fracture or cardiac surgery, as well as those requiring intensive care following a surgical intervention or multiple trauma (high risk patients). METHODS: We documented rates of allogeneic red cell transfusion in 41,568 patients admitted to 11 hospitals across Canada between August 1998 and August 2000 as part of a retrospective observational cohort study. In the subgroup of 7,552 patients receiving red cells, we also compared mean nadir hemoglobin concentrations from centre to centre. RESULTS: The overall rate of red cell transfusion was 38.7%, and ranged from 23.8% to 51.9% across centres among the 41,568 perioperative and critically ill patients. Women were more likely to be transfused (43.7% vs 35.3%, P < 0.0001), with higher rates of transfusion in eight of 11 centres. Compared to a chosen reference hospital having a crude transfusion rate near the median, the adjusted odds of transfusion ranged from 0.44 to 1.53 overall, from 0.42 to 1.22 in patients undergoing a hip fracture repair, from 0.72 to 3.17 in cardiac surgical patients undergoing cardiac surgery, and from 0.27 to 1.11 in critically ill and trauma patients. In the 7,552 transfused patients, the mean adjusted nadir hemoglobin was 74.0 +/- 4.83 g x L(-1) overall, and ranged from 66.9 +/- 1.7 g x L(-1) to 84.5 +/- 1.6 g x L(-1) across centres. Similar differences among centres were observed amongst hip fracture patients (71.2 +/- 2.9 g x L(-1) to 82.8 +/- 1.7 g x L(-1)), cardiac surgical patients (65.7 +/- 1.1 g x L(-1) to 77.3 +/- 1.0 g x L(-1)) and critically ill and trauma patients (66.1 +/- 3.04 g x L(-1) to 87.5 +/- 2.5 g x L(-1)). CONCLUSION: We noted significant differences in the rates of red cell transfusion and nadir hemoglobin concentrations in various surgical and critical care settings.
PURPOSE: To document variation of transfusion practice following repair of hip fracture or cardiac surgery, as well as those requiring intensive care following a surgical intervention or multiple trauma (high risk patients). METHODS: We documented rates of allogeneic red cell transfusion in 41,568 patients admitted to 11 hospitals across Canada between August 1998 and August 2000 as part of a retrospective observational cohort study. In the subgroup of 7,552 patients receiving red cells, we also compared mean nadir hemoglobin concentrations from centre to centre. RESULTS: The overall rate of red cell transfusion was 38.7%, and ranged from 23.8% to 51.9% across centres among the 41,568 perioperative and critically ill patients. Women were more likely to be transfused (43.7% vs 35.3%, P < 0.0001), with higher rates of transfusion in eight of 11 centres. Compared to a chosen reference hospital having a crude transfusion rate near the median, the adjusted odds of transfusion ranged from 0.44 to 1.53 overall, from 0.42 to 1.22 in patients undergoing a hip fracture repair, from 0.72 to 3.17 in cardiac surgical patients undergoing cardiac surgery, and from 0.27 to 1.11 in critically ill and traumapatients. In the 7,552 transfused patients, the mean adjusted nadir hemoglobin was 74.0 +/- 4.83 g x L(-1) overall, and ranged from 66.9 +/- 1.7 g x L(-1) to 84.5 +/- 1.6 g x L(-1) across centres. Similar differences among centres were observed amongst hip fracturepatients (71.2 +/- 2.9 g x L(-1) to 82.8 +/- 1.7 g x L(-1)), cardiac surgical patients (65.7 +/- 1.1 g x L(-1) to 77.3 +/- 1.0 g x L(-1)) and critically ill and traumapatients (66.1 +/- 3.04 g x L(-1) to 87.5 +/- 2.5 g x L(-1)). CONCLUSION: We noted significant differences in the rates of red cell transfusion and nadir hemoglobin concentrations in various surgical and critical care settings.
Authors: Alexander P J Vlaar; Anne L In der Maur; Jan M Binnekade; Marcus J Schultz; Nicole P Juffermans Journal: Blood Transfus Date: 2009-04 Impact factor: 3.443
Authors: A B Pedersen; D Cronin Fenton; M Nørgaard; N R Kristensen; B Kuno Møller; C Erikstrup Journal: Osteoporos Int Date: 2016-04-21 Impact factor: 4.507
Authors: Lavanya Yohanathan; Natalie G Coburn; Robin S McLeod; Daniel J Kagedan; Emily Pearsall; Francis S W Zih; Jeannie Callum; Yulia Lin; Stuart McCluskey; Julie Hallet Journal: J Gastrointest Surg Date: 2016-03-29 Impact factor: 3.452
Authors: I Cortés-Puch; B M Wiley; J Sun; H G Klein; J Welsh; R L Danner; P Q Eichacker; C Natanson Journal: Transfus Med Date: 2018-04-19 Impact factor: 2.019
Authors: Nareg H Roubinian; Gabriel J Escobar; Vincent Liu; Bix E Swain; Marla N Gardner; Patricia Kipnis; Darrell J Triulzi; Jerome L Gottschall; Yan Wu; Jeffrey L Carson; Steven H Kleinman; Edward L Murphy Journal: Transfusion Date: 2014-08-18 Impact factor: 3.157
Authors: Jill J Francis; Alan Tinmouth; Simon J Stanworth; Jeremy M Grimshaw; Marie Johnston; Chris Hyde; Charlotte Stockton; Jamie C Brehaut; Dean Fergusson; Martin P Eccles Journal: Implement Sci Date: 2009-10-24 Impact factor: 7.327